Ardelyx, Inc. (ARDX) Financials

ARDX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 504.5 million 355.9 million
Dec. 31, 2025 502.8 million 335.9 million
Sept. 30, 2025 486.2 million 331.9 million
June 30, 2025 466.8 million 327.2 million

ARDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -32.3 million 14.2 million
Dec. 31, 2025 20.6 million 12.4 million
Sept. 30, 2025 209000 12.7 million
June 30, 2025 -26.0 million 11.7 million

ARDX Net Income

No data available :(

ARDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 238.1 million 203.5 million 4.7 million
Dec. 31, 2025 264.7 million 206.5 million 3.6 million
Sept. 30, 2025 242.7 million 202.1 million 5.5 million
June 30, 2025 238.5 million 201.4 million 5.2 million

ARDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 245.9 million
Dec. 31, 2025 243.6 million
Sept. 30, 2025 241.9 million
June 30, 2025 239.9 million

ARDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 69000 20.2 million 102.3 million -
Dec. 31, 2025 361000 21.9 million 86.4 million -
Sept. 30, 2025 156000 17.2 million 83.6 million -
June 30, 2025 650000 15.0 million 84.0 million -

ARDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 94.5 million 4.8 million
Dec. 31, 2025 125.2 million 11.8 million
Sept. 30, 2025 110.3 million 4.9 million
June 30, 2025 97.7 million 13.0 million

ARDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ARDX

Price: $5.68

52 week price:
3.49
8.40

Earnings Per Share: -0.24 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 8.1 million

Ebitda: -20.5 million

Market Capitalization: 1.4 billion

Links: